MedPath

Safety Evaluation of Propofol Sedation for Magnetic Resonance Imaging in Pediatric Patients

Completed
Conditions
Multiparametric Magnetic Resonance Imaging
Propofol Adverse Reaction
Sedation Complication
Anesthesia; Adverse Effect
Registration Number
NCT04455776
Lead Sponsor
Brugmann University Hospital
Brief Summary

Propofol is often used for sedation in children undergoing magnetic resonance imaging. The investigators will perform a chart review of 4 month of activity (about 100 cases) and review the incidence and severity of adverse events of this sedation technique.

Detailed Description

Magnetic resonance imaging in children, especially under 6 years of age, is often performed under sedation. Propofol is a common drug used in this settings. In our institution, sedation is most often done by a propofol bolus of 2-5 mg/kg in order to reach a deep level of sedation as defined by Coté et al. If judged necessary by the attending anaesthesiologist, a additional propofol bolus of 0.5-1 mg/kg may be given. For longer lasting exams, the attending anaesthesiologist can chose to use a continuous infusion of propofol. The investigators will review the charts of 4 month of magnetic resonance imaging, which will give us a cohort of about 100 patients. Baseline characteristics, detailed sedation technique used will be recorded. Adverse events defined as:

* Oxygen desaturation measured by transcutaneous oximetry SpO2≤94%

* hypercapnia measure by end-tidal CO2 \>45 mm Hg

* movement of the patient

Assuming a non-normal distribution (tested by a Kolmogorov-Smirnov test), variables will be reported as median and interquartile range. Statistical tests will be done by non-parametric tests, Mann Whitney U. Non continuous variables will be analyzed by a Chi-square test.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
99
Inclusion Criteria
  • Pediatric patients scheduled for MRI under sedation by an anaesthesiologist
  • Age < 16 years
Exclusion Criteria
  • Age > 16 years
  • Sedation performed by a non-anesthesiologist

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hypoxemia90 minutes

Arterial desaturation defined as number of episodes with an SpO2≤94%

Hypercapnia90 minutes

Hypercapnia, defined as number of episodes with an ETCO2 \> 45 mm HG

Movements90 minutes

Number of patient movements interfering with the MRI exam

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital Universitaire des Enfants Reine Fabiola

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath